人口老龄化的药物:EMA的前景和政策
Francesca Cerreta1, Ewa Balkowiec Iskra2,3, Amelia Cupelli4
1European Medicines Agency, Amsterdam, Noord-Holland, Netherlands.
Journal of the American Geriatrics Society
|May 17, 2024
概括
欧洲药品管理局 欧洲药品管理局
科学领域:
- 老年人药理学和调控科学.
- 对老年人的药物开发和评估.
- 基于证据的医学和监管政策.
背景情况:
- 欧洲药品署的老年病药物战略成立于十多年前.
- 该战略重点是针对老年人药物授权的证据和发现的沟通.
- 在过去的十年中,新的工具和数据源已经出现,以帮助战略实施.
研究的目的:
- 审查和提出具体行动,以改善老年医学在药物开发中的整合.
- 加强对老年人群的临床试验设计,数据收集,评估和沟通.
- 确保在开发和评估药物时,考虑到老年患者的特殊需求.
主要方法:
- 审查现有战略和新兴工具/数据源.
- 建议采取具体行动,改善药物开发中的老年医学方面.
- 在实施过程中考虑资源效率和患者需求.
主要成果:
- 确定了针对老年人群的临床试验设计需要改进的领域.
- 强调需要加强批准前和批准后的数据收集和评估.
- 强调了改善的沟通策略,以便在老年人中提供明智的处方和安全的药物使用.
结论:
- 将老年病方面的因素纳入常规医学开发和评估是可行的,也是必要的.
- 优先考虑的行动应侧重于患者的需求和有效的资源利用.
- 持续适应和使用新工具对于战略的成功至关重要.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.5K
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Prescription, Nonprescription and Orphan Drugs
721
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
721
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
